静脉注射铁用于心力衰竭中的铁缺乏症,具有保存的喷射分数. 一个多变量分析
Noverraz Viviane1,2, Carballo Sebastian3,2, Carballo David4,2
1Division of Internal medicine, Riviera Chablais Hospital, Switzerland.
概括
静脉注射铁并没有降低心力衰竭与保存喷射分数 (HFpEF) 和缺铁 (ID) 的住院患者的一年死亡率或再入院风险. 这项研究强调了HFpEF中ID的患病率,但没有显示急性IV铁治疗的益处.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是最常见的心力衰竭类型.
- 铁缺乏症 (ID) 是HFpEF中常见的并发症,与患者的治疗结果更差有关.
- 了解HFpEF中缺铁治疗的影响对于改善患者管理至关重要.
研究的目的:
- 研究静脉注射 (IV) 铁对HFpEF和铁缺乏症患者一年死亡或再住院风险的影响.
- 评估急性HFpEF住院患者中缺铁的患病率.
- 评估IV铁治疗在急性HF住院期间的安全性和有效性.
主要方法:
- 分析了日内瓦大学医院467名急性心力衰竭患者的潜在注册表.
- 对HFpEF和铁缺乏症患者进行比较,基于他们在住院期间是否接受了静脉注射铁.
- 为了调整基线失衡和预后因素,使用了COX比例危险模型,主要终点是急性HF或所有原因死亡的一年内再入院风险.
主要成果:
- 在包括的HFpEF患者中,有54%的患者存在铁缺乏症.
- 静脉注射铁给了22.7%的患者,他们更有可能患有贫血.
- 在静脉铁替代 (46%) 和非替代 (43%) 组 (HR1.08;95% CI 0.66-1.76) 之间,与HF相关的一年死亡或再住院的风险相似.
结论:
- 在急性心力衰竭的住院患者中,缺铁非常普遍,许多人没有接受铁补充剂.
- 在急性HFpEF住院期间静脉注射铁并没有显著改变一年死亡或急性HF再入院的风险.
- 需要进一步的研究来确定铁缺乏症HFpEF患者铁疗法的最佳时间和治疗方案.
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
41
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
41
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
01:29Heart Failure II: Pathophysiology
54
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
54
01:26Heart Failure III: Clinical Manifestations
59
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
59
01:22Heart Failure VI: Adjunct Therapies
38
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
38
01:30Heart Failure V: Medical Management
33
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
33